Shukra Pharma - RELISH, 524632 corporate action history

Shukra Pharmaceuticals Ltd.

BSE: 524632

Expensive Performer

Download real time

31.75 -1.09 (-3.32%)

51.35% Fall from 52W High

144.2K

BSE Volume

BSE 22 Jul, 2026 1:21 PM (IST)

Bonus history for Shukra Pharma

Shukra Pharma has given 1 bonus since April 19, 2024. The last Bonus that Shukra Pharma anoununced was in the ratio 3:1 with ex-date of April 19, 2024.

Ex-Date	Bonus Ratio	Record Date
19 Apr 2024	3:1	20 Apr 2024

See all forthcoming Bonus and split

Split history for Shukra Pharma

Shukra Pharma has split the face value 1 time since March 21, 2025. Shukra Pharma had last split the face value of its shares from ₹10 to ₹1 in 2025.The share has been quoting on an ex-split basis from March 21, 2025.

Ex-Date	Old FV	New FV	Record Date
21 Mar 2025	10	1	21 Mar 2025

See all forthcoming Bonus and split

Dividend history for Shukra Pharma

Shukra Pharma has declared 6 dividends since Aug. 31, 2018.

In the past 12 months, Shukra Pharma has declared an equity dividend amounting to ₹0.01 per share.

At the current share price of ₹31.7500, Shukra Pharma's dividend yield is 0.03%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Sep 2025	0.010	FINAL	18 Sep 2025	Equity Share
23 Sep 2024	1.000	FINAL	-	Equity Share
15 Sep 2023	0.500	FINAL	-	Equity Share
22 Sep 2022	0.500	FINAL	-	Equity Share
19 Sep 2019	0.500	FINAL	-	Equity Share
31 Aug 2018	0.500	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Shukra Pharma

The latest board meeting for Shukra Pharma took place on 10 Jun 2026, for the purpose of Others

Ex-Date	Purpose	Notes
10 Jun 2026	Others	Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters.
07 May 2026	Audited Results & Final Dividend	-
16 Mar 2026	Others	Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters.
04 Feb 2026	Quarterly Results	(Revised)
13 Nov 2025	Quarterly Results	-
03 Oct 2025	Others	Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters.
13 Aug 2025	Quarterly Results	-
04 Jun 2025	Final Dividend	-
29 May 2025	Audited Results	-
14 Feb 2025	Quarterly Results	-

See all Board Meetings for Shukra Pharma

Rights history for Shukra Pharma

Shukra Pharma issued rights 1 time since Feb. 2, 2023. Shukra Pharma had last issued Rights shares of ₹10.0/- in the ratio of 6.0:1.0 @ premium of ₹10.0/- on Feb. 2, 2023.

Ex-Date	Ratio	Face Value	Premium	Record Date
02 Feb 2023	6.0:1.0	10.0	10.0	02 Feb 2023

See all Rights History for Shukra Pharma

Is Shukra Pharmaceuticals Ltd. worth buying?

63 Votes:

Buy 74.6%

Sell 14.29%

Hold 11.11%